Multicentre study ‘rehabilitation of occupational skin diseases –optimization and quality assurance of inpatient management (ROQ)’–results from 12‐month follow‐up

Weißhaar, Elke; Skudlik, Christoph; Scheidt, Reginald; Matterne, Uwe; Wulfhorst, Britta; Schönfeld, Michael; Elsner, Peter; Diepgen, Thomas L.; John, Swen Malte

doi:10.1111/j.1600-0536.2012.02170.x

Cited by 90 publications

(98 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…These data confirm severity and chronicity of CHE in affected patients. In Germany the social security system covers treatment of severe occupational skin disease (OSD) by means of interdisciplinary in-patient rehabilitation measures with the goal of avoiding loss or change of job (16,17). The comparatively high figure for in-patient treatment can thus be explained by the fact that specialized centres for occupational dermatology offering such rehabilitation measures contribute significantly to the CARPE registry.…”

Section: Discussionmentioning

confidence: 98%

Characteristics and Provision of Care in Patients with Chronic Hand Eczema: Updated Data from the CARPE Registry

Apfelbacher¹,

Molin²,

Weißhaar³

et al. 2014

Acta Derm Venerol

View full text Add to dashboard Cite

The aim of the CARPE registry is to investigate characteristics and medical care in patients affected by chronic hand eczema. Patients are assessed by dermatological examination and patient questionnaire. Socio-economic and clinical data are collected, and quality of life is measured using the Dermatology Life Quality Index (DLQI). A total of 1,163 patients with chronic hand eczema were eligible for analysis (mean age 47.0 years; 54.6% female; mean disease duration 7.6 years). At inclusion, chronic hand eczema was very severe in 23.4%, severe in 47.0%, moderate in 20.1%, and clear or almost clear in 9.6% of patients. Median DLQI was 8.0. In all, 93.8% of patients reported use of topical corticosteroids, 25.6% systemic antihistamines, 28.3% topical calcineurin-inhibitors, 38.0% ultraviolet phototherapy, and 35.3% systemic treatment (19.7% alitretinoin) prior to inclusion in the registry. A significant proportion of patients may not receive adequate treatment according to the guideline on management of hand eczema.

show abstract

Section: Discussionmentioning

confidence: 98%

Characteristics and Provision of Care in Patients with Chronic Hand Eczema: Updated Data from the CARPE Registry

Apfelbacher¹,

Molin²,

Weißhaar³

et al. 2014

Acta Derm Venerol

View full text Add to dashboard Cite

show abstract

“…This 12-month follow-up study revealed the persistence of the previously reported more immediate reductions in severity of OSD, topical steroid use, and number of days of absence from work and improvements in quality of life. These results indicated that the tertiary individual prevention [dermatological treatment and diagnostic procedures and patient education (health and psychological)] provided a reduction in the personal and public burden of OSD [34].…”

Section: Management and Preventionmentioning

confidence: 92%

Recent Trends in Occupational Contact Dermatitis

Wiszniewska

Walusiak‐Skorupa

2015

Curr Allergy Asthma Rep

View full text Add to dashboard Cite

Occupational contact dermatitis (OCD) remains prevalent among workers and impacts quality of life and workability. The purpose of this review is to summarize the recent advances in occupational contact dermatitis as well as potential hazardous agents in the workplaces causing OCD. The review covers new developments in the epidemiology, etiology, diagnosis, and management of occupational contact dermatitis. This article also provides updated information on the prevalence of work-related skin symptoms and on new contact allergens among working population. It is emphasized that in the context of prevention of OCD, special attention should be focused on the identified high-risk occupational groups, especially healthcare workers and hairdressers starting with the apprentices. Current approaches include working out the standards and guidelines to improve the education, knowledge, diagnosis, and management of OCD based on a multidisciplinary team of medical specialists and an employer.

show abstract

“…The worker may need to receive workers' compensation and disability benefit after establishing occupational causation while considering retraining for a new job. The cost of early consideration for rehabilitation may be financially beneficial (Weisshaar et al, 2013;Van Gils et al, 2012a,b;Gomez et al, 2011;Holness, 2003).…”

Section: Rehabilitationmentioning

confidence: 98%

Management of contact dermatitis

Al-Otaibi

Alqahtani

2015

Journal of Dermatology & Dermatologic Surgery

View full text Add to dashboard Cite

Skin disorders compromise more than 35% of all occupationally related disorders. Most of these are contact dermatitis as a result from contact with a chemical substance. Contact dermatitis can be either irritant or allergic type. Each type has a different mechanism while the clinical presentation is the same. Management of contact dermatitis must include both medical treatment and workplace modifications as appropriate to reduce exposure to the causative agents. Physicians should be aware of this preventable medical condition. Ó 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

show abstract

Multicentre study ‘rehabilitation of occupational skin diseases –optimization and quality assurance of inpatient management (ROQ)’–results from 12‐month follow‐up

Cited by 90 publications

References 25 publications

Characteristics and Provision of Care in Patients with Chronic Hand Eczema: Updated Data from the CARPE Registry

Characteristics and Provision of Care in Patients with Chronic Hand Eczema: Updated Data from the CARPE Registry

Recent Trends in Occupational Contact Dermatitis

Management of contact dermatitis

Contact Info

Product

Resources

About